Protas welcomes the Good Clinical Trials Collaborative

Protas becomes the new host organisation for the Good Clinical Trials Collaborative.

The Collaborative, led by Prof Sir Martin Landray, has developed guidance to set and promote a new international benchmark of scientific rigour, ethical integrity, efficiency and quality for randomised controlled trials (RCTs).

The guidance describes the key principles of RCTs: what makes an RCT good in its design and analysis, as well as ethical and social value; and why this is so.

This guidance aims to enable those involved in RCTs to work out for themselves how to design and deliver their particular RCT in their particular setting.

Launched in June 2020 and supported by grants from Wellcome and the Bill & Melinda Gates Foundation, the Collaborative has brought together a wide range of individuals and organisations with an interest in and role to play in the design, delivery, analysis and reporting of randomised trials, and in implementing the results.

This includes those who fund, regulate, design, deliver or are responsible for such trials, those who provide audits and quality assurance functions, research organisations, clinicians, participants, ethicists, and lay health advocates.

It includes those from a wide variety of sectors (industry, academia, government, charitable, non-governmental organisations, participant and public groups) and global settings.

You can keep up to date with the Collaborative’s work here.